Gynecologic pathology focuses on tissue-based diagnosis of neoplastic and non-neoplastic diseases of the female genital tract, including cancer. Gynecologic cancers afflict an estimated 330,000 women or more in the United States each year. If detected and diagnosed correctly and early enough, chances of patient survival rise dramatically. Therefore, it is critical for pathologists to have the skills to diagnose accurately based on testing results.

Whether refreshing or expanding their knowledge, pathologists can count on the CAP to help them stay current with ongoing diagnostic learning and other skills related to gynecologic pathology. The CAP offers several continuing medical education (CME) online courses in gynecologic pathology in a focused format. By learning on individual topics in bite-sized courses, the pathologist can spend more time on what matters – patient care.

Ten Perinatal Diagnoses You Don’t Want to Miss and Why

This course focuses on placental pathologies affecting the mother and infant. It discusses what activity will identify ten perinatal diagnoses, as well as interventions to mitigate risk: chronic histiocytic intervillositis, massive perivillous fibrin deposition (maternal floor infarct), candida placentitis, CMV placentitis, maternal vascular malperfusion, massive villous edema, inborn errors of metabolism, fetal vascular malperfusion, meconium myonecrosis, and basal plate myometrial fibers.

Course Author:

Drucilla J. Roberts, MD, FCAP
Massachusetts General Hospital

Learn More

 

A Clinically Relevant Pattern-Based Approach to Diagnosing Uterine Mesenchymal Tumors

A pattern-based approach (spindled, epithelioid, rhabdoid, myxoid patterns; low-grade versus high-grade atypia) can build differential diagnoses and emphasize selection and interpretation of the most useful, current immunohistochemistry (IHC) and molecular tests for each diagnostic scenario of uterine mesenchymal tumors. The course highlights common pitfalls, new diagnostic tools, and features that predict response to targeted therapy; and the novel role of the pathologist in recognizing morphologic features associated with risk of a hereditary syndrome.

Course Authors:

Jennifer Bennett, MD, FCAP
University of Chicago Medical Center		Joseph Rabban, MD, MPH, FCAP
University of California San Francisco

Learn More

 

Benign Isn’t Boring: Daily Difficulties in Endometrial Biopsies that Go Beyond Classifying Cancer

Four key areas of benign endometrial pathology can routinely result in questions among colleagues or might prompt sending endometrial biopsies out for consultation. The course uses case studies to examine progestin treatment effects, subcarcinoma-threshold mucinous and papillary surface proliferations of the endometrium, endometrial histiocytic proliferations, and unusual endometrial polyps.

Course Authors:

Amy Joehlin-Price, MD, MS, FCAP
Cleveland Clinic

Learn More

 

What's in a Name? Serous Neoplasms of the Ovary and Fallopian Tube: Classification Updates, Common Conundrums, and Outcomes

The practicing pathologist, whether in a community or academic setting, commonly encounters serous neoplasms of the ovary and fallopian tube that may pose diagnostic dilemmas. This course reviews problematic cases of high-grade serous carcinoma, including diagnosis and reporting of post-neoadjuvant high-grade serous carcinoma, overlap with low-grade carcinoma, and diagnostic features of serous tubal intraepithelial carcinoma.

Course Authors:

Natalie Banet, MD, FCAP
Cleveland Clinic		Deyin Xing, MS, BM, MBBS, PhD
John Hopkins University School of Medicine

Learn More

 

Molar Disease and Molar Mimics

Course Author



Sarah Chiang, MD, FCAP
Memorial Sloan Kettering Cancer Center

 

This course will address hydatidiform moles and their histologic mimics and how to recognize hydatidiform moles and distinguish them from non-molar lesions such as early hydropic abortus, placental mesenchymal dysplasia, and ectopic pregnancy. To facilitate accurate diagnosis of these entities, the course also discusses the usefulness of IHC and molecular genetic assays in diagnosing difficult cases.

Learn More

 

Contact Us

If you have any questions, please contact the CAP: 800-323-4040 option #1
Email: [email protected]